Takaaki Hirotsu

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Hirotsu Bio Science Inc., Nanpuh Hospital, Kumamoto University. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaaki Hirotsu. Retrieved from https://idiyas.com/inventor/takaaki-hirotsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Fukuoka, JP (2023)
Tokyo, JP (2021 - 2024)

Company Filing History:

8 out of 11

Hirotsu Bio Science Inc.

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12669506 - CANCER DETECTION METHOD USING SENSE OF SMELL OF NEMATODE (2026-06-30),

2. 12498362 - Method for examining cancer in pet animal (2025-12-16),

3. 12493040 - CANCER DETECTION METHOD USING SENSE OF SMELL OF NEMATODE (2025-12-09),

4. 12019068 - Method for predicting therapeutic effect and/or recurrence monitoring in cancer patients (2024-06-25),

5. 11725226 - Method for detecting kidney cancer (2023-08-15),

6. 11719698 - Cancer detection method using sense of smell of nematode (2023-08-08),

7. 11479800 - Cancer detection method using tissue specimen (2022-10-25),

8. 11150234 - Method for evaluating taxic behavior in response to odor substance based on olfactory sense in nematodes, and dish and behavior evaluation system used in evaluation method (2021-10-19),

Title: Takaaki Hirotsu: Innovator in Cancer Detection

Introduction

Takaaki Hirotsu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer detection and treatment monitoring. With a total of 8 patents, Hirotsu's work focuses on innovative methods that enhance the accuracy of cancer diagnostics.

Latest Patents

Hirotsu's latest patents include a method for predicting therapeutic effects and monitoring recurrence in cancer patients. This invention provides a novel approach to detecting the therapeutic effect of cancer treatment by measuring nematode tactic behavior in response to urine samples from patients. The method involves comparing pre-treatment and post-treatment urine samples to determine the effectiveness of the treatment. Another significant patent is a method for detecting kidney cancer, which allows for highly sensitive and specific detection through the analysis of diluted urine samples and nematode attraction behavior.

Career Highlights

Throughout his career, Takaaki Hirotsu has worked with notable organizations such as Hirotsu Bio Science Inc. and Nanpuh Hospital. His experience in these institutions has allowed him to develop and refine his innovative methods for cancer detection.

Collaborations

Hirotsu has collaborated with esteemed colleagues, including Takayuki Uozumi and Satoru Kaifuchi. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Takaaki Hirotsu is a key figure in the field of cancer detection, with a focus on innovative methods that improve patient outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.